Whitehawk Therapeutics (WHWK) Net Cash Flow: 2018-2025
Historic Net Cash Flow for Whitehawk Therapeutics (WHWK) over the last 8 years, with Sep 2025 value amounting to -$107.0 million.
- Whitehawk Therapeutics' Net Cash Flow fell 909.29% to -$107.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.3 million, marking a year-over-year increase of 119.16%. This contributed to the annual value of -$34.2 million for FY2024, which is 243.36% down from last year.
- As of Q3 2025, Whitehawk Therapeutics' Net Cash Flow stood at -$107.0 million, which was down 29.49% from -$82.6 million recorded in Q2 2025.
- In the past 5 years, Whitehawk Therapeutics' Net Cash Flow ranged from a high of $198.8 million in Q1 2025 and a low of -$107.0 million during Q3 2025.
- In the last 3 years, Whitehawk Therapeutics' Net Cash Flow had a median value of -$5.9 million in 2023 and averaged -$104,727.
- As far as peak fluctuations go, Whitehawk Therapeutics' Net Cash Flow tumbled by 1,753.98% in 2024, and later surged by 2,283.08% in 2025.
- Over the past 5 years, Whitehawk Therapeutics' Net Cash Flow (Quarterly) stood at -$12.4 million in 2021, then plummeted by 673.42% to -$95.8 million in 2022, then skyrocketed by 93.83% to -$5.9 million in 2023, then spiked by 68.44% to -$1.9 million in 2024, then crashed by 909.29% to -$107.0 million in 2025.
- Its Net Cash Flow stands at -$107.0 million for Q3 2025, versus -$82.6 million for Q2 2025 and $198.8 million for Q1 2025.